Company Filing History:
2 out of 2 
1 out of 14 Years Active: 2011-2025
Title: The Innovative Contributions of Steven Glazer
Introduction
Steven Glazer is a notable inventor based in Weston, Connecticut, who has made significant contributions to the field of neurodegenerative disease research. With a total of three patents to his name, Glazer's work focuses on innovative treatments and preventive measures for neuropathology associated with these diseases.
Latest Patents
One of Glazer's latest patents addresses the treatment and prevention of neuropathology associated with neurodegenerative diseases. This patent describes a method of administering a live, attenuated-based vaccine to subjects at risk for developing neurodegenerative diseases featuring Aβ brain plaques. The vaccine aims to prevent or reduce the amount of Aβ brain plaques that would have developed in the subject without such treatment. This innovative approach has the potential to change the landscape of neurodegenerative disease management.
Career Highlights
Throughout his career, Steven Glazer has worked with various companies, including Iliad Biotechnologies, LLC and Seedlings Life Science Ventures, LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology and medical research.
Collaborations
Some of Glazer's notable coworkers include Keith Rubin and Marina Lynch. Their collaborative efforts have likely played a role in the development of his patents and the advancement of research in neurodegenerative diseases.
Conclusion
Steven Glazer's work exemplifies the spirit of innovation in the field of neurodegenerative disease research. His patents and collaborations highlight his commitment to finding effective treatments and preventive measures for these challenging conditions.